BioSpace News Archive

Biotech Beach

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - December 15, 2022

Arrowhead Pharmaceuticals, Inc. announced that as an inducement to entering into employment with the Company, on December 9, 2022, the Compensation Committee of the Company’s Board of Directors approved “inducement” grants to 35 new employees under Rule 5635 of the NASDAQ Listing Rules.

December 15, 2022
·
1 min read
Business

Verastem Oncology Appoints Rob Gagnon to Board of Directors

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced the appointment of Robert Gagnon to its Board of Directors, effective December 13, 2022.

December 15, 2022
·
7 min read
Infermedica Celebrates Record Year, Accelerating Momentum Into 2023

Infermedica today reflects on the major milestones it has achieved throughout 2022 and looks forward to its continued growth in the new year.

December 15, 2022
·
3 min read
Policy

Press Release: Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo nodularis

The European Commission has expanded the marketing authorization for Dupixent® in the European Union to treat adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy.

December 15, 2022
·
17 min read
Business

Q2 Interim Report August-October 2022/2023

Biovica International Successful capital acquisition paves the way for launch in the USA

December 15, 2022
·
5 min read
Business

Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer

Comanche Biopharma announced that maternal health, vaccine and drug development expert Allison August, M.D., has been appointed as the company´s Chief Medical Officer.

December 15, 2022
·
5 min read
Pharm Country

Cell and Gene Therapy Companies Leverage GenScript’s cGMP sgRNA Capability to Accelerate Speed to Market

GenScript USA Inc. recently expanded its global current Good Manufacturing Practices (cGMP) single-guide RNA (sgRNA) manufacturing capabilities to meet the growing demand for cell and gene therapies.

December 15, 2022
·
4 min read
Pharm Country

Teleflex Celebrates 400,000 Patients Treated With the Minimally Invasive UroLift® System

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that 400,000 patients have now been treated with the UroLift ® System, 1 a safe, effective and minimally invasive treatment option for benign prostatic hyperplasia (BPH), or enlarged prostate.

December 15, 2022
·
5 min read
Medtronic announces first patient enrolled in U.S. clinical trial for Hugo™ robotic-assisted surgery system

Medtronic plc today announced the first patient enrolled in the Expand URO U.S. clinical trial for the Hugo™ robotic-assisted surgery.

December 15, 2022
·
4 min read
Business

AstraZeneca and Merck Provide Update on US Regulatory Review of LYNPARZA® (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone as Treatment of Metastatic Castration-Resistant Prostate Cancer

AstraZeneca and Merck Provide Update on US Regulatory Review of LYNPARZA ® (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone as Treatment of Metastatic Castration-Resistant Prostate Cancer.

December 15, 2022
·
19 min read